Skip to main navigation
Skip to search
Skip to main content
Columbia University Home
Help & FAQ
English
Français
Español
Home
Profiles
Research units
Research output
Equipment
Datasets
Projects & Clinical Trials
Activities
Prizes
Courses
Student theses
Search by expertise, name or affiliation
Therapeutic Resistance to BRAF/MEK inhibitors in BRAF-mutant Melanoma
Yang, Hee Won H.W.
(PI)
Columbia University Irving Medical Center
Project
:
Research project
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cancer Cell
100%
MEK Inhibitor
100%
Melanoma
100%
Drug Resistance
83%
Cell Proliferation
50%
Neoplasm
33%
Resistance Mutation
33%
Melanoma Cell
33%
Skin Cancer
16%
Drug Therapy
16%
Metastatic Melanoma
16%
Gene Mutation
16%
Recurrent Disease
16%
Malignant Neoplasm
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Melanoma
100%
Mitogen Activated Protein Kinase Kinase Inhibitor
100%
Drug Resistance
71%
Neoplasm
28%
Recurrent Disease
14%
Metastatic Melanoma
14%
Pharmacotherapy
14%
Skin Cancer
14%
Gene Targeting
14%